Stock screenerAll disclosures →
EDGAR →
MGNX
Conviction 86HealthcareScan · Mon, Aug 10, 2026MGNX$4.09+1.24%
ResistanceSupportVol 14Vol MA14 854.95K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price4.09
Change+1.24%
Gap+0.50%
Rel volume3.81×
Avg volume851.17K
Avg $ vol3.44M
SMA 204.04
SMA 504.22
SMA 2002.78
Price vs 50-3.08%
Price vs 200+46.89%
MA stackmixed
50/200 cross—
Supertrenddown · 4.64
RSI (14)50
MACD hist0.02
MACD crossbull · 1d
Stoch %K / %D58 / 55
ADX (14)26
+DI / −DI15 / 20
RSI divergence—
MACD divergence—
ATR %+6.39%
ADR %6.75%
52w high4.86
52w low1.33
From 52w high-15.84%
Above 52w low+207.52%
New 52w highNo
SqueezeOff
Bollinger width25.40%
%B0.55
Donchian pos57.48%
Donchian high4.63
Donchian low3.36
AVWAP (52w high)4.40
vs AVWAP high-7.06%
AVWAP (52w low)2.85
vs AVWAP low+43.67%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d3.81×
Avg vol (14d)854.95K
Avg vol (20d)851.17K
Avg $ vol (20d)3.44M
Market cap259.97M
RS 3m (vs SPY)+31.72%
RS 6m (vs SPY)+123.53%
RS line new highNo
Trend template7/8
Technical rank68.9
1 week+7.07%
1 month-5.54%
3 months+36.33%
6 months+125.97%
1 year+154.04%
YTD+154.04%
P/E-3.48
P/B12.26
P/S1.74
P/FCF-3.13
EPS-1.18
Div yield—
ROE-352.01%
ROA-34.25%
Debt/Eq—
Current1.90
EV/EBITDA-2.95
Gross margin—
Net margin-49.91%
Rev growth-0.31%
EPS growth-11.43%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value193.46M
Revenue20.77M
Net income-36.77M
Gross profit—
Free cash flow-82.95M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees293
ListedThu, Oct 10, 2013
Free float61.53M
Float %97.3%
Short interest5.69M
Days to cover6.8d
Short volume60.7%
Squeeze score72 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank68.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.07
Support3.49
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MGNX
No recent disclosed trades by Congress in MGNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MGNX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
HEIDEN WILLIAM K Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
Jackson Scott Thomas Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
Koenig Scott Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
Liu Margaret Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
STUMP DAVID C Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
STUMP DAVID C Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
Koenig Scott Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
Ferrante Karen Jean Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
Chhabra Meenu Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
HURWITZ EDWARD Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
SEC filings
EDGAR filings in MGNX · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.